November 08, 2012 at 18:47 PM EST
Sun Pharmaceutical To Acquire Dusa Pharmaceuticals
Sun Pharmaceutical Industries Ltd. will pay a premium of $8 per share in cash to acquire Dusa Pharmaceuticals Inc. (Nasdaq: DUSA) sending the stock price soaring $2.17 to close at $7.95.

Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here